FDA panel recommends authorizing Pfizer COVID-19 vaccine for younger kids
| A key Food and Drug Administration (FDA) expert advisory panel on Tuesday recommended the agency authorize Pfizer’s COVID-19 vaccine for use in children between the ages of 5 and 11. |
